S&P's Top Biotech Beneficiaries of Health Care Reform
With the passage of the U.S. Senate's version of the health care reform bill on Christmas Eve, investors may now want to take a look at the growth prospects for the biotech industry. It's likely to benefit from the legislation that's leading to a major health care industry overhaul in 2010. Continue reading S&P's Top Biotech Beneficiaries of Health Care Reform S&P's Top Biotech Beneficiaries of Health Care Reform originally appeared on DailyFinance on Sun, 27 Dec 2009 12:00:00. Filed Under: Investing , Healthcare Permalink | Tweet this! | Comments
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here